Trulieve Cannabis Corp. reported second-quarter 2026 revenue of $271 million. Gross margin was 60%. Adjusted EBITDA was $98 million.
The company highlighted its successful uplisting to the New York Stock Exchange. It also discussed the positive impacts of federal cannabis rescheduling, which it said it helped support.
Looking ahead, Trulieve expects growth in Georgia and Pennsylvania to offset seasonal pressure in its home market of Florida. It anticipates growth will accelerate by year-end.
The company revised its full-year 2026 guidance, forecasting operating cash flow of at least $225 million. It raised its capital expenditure forecast to $95 million to support expansion in growth markets.